When BAD Is Good for β Cells  by Philipson, Louis H. & Roe, Michael W.
Cell Metabolism
PreviewsWhen BAD Is Good for b Cells
Louis H. Philipson1,* and Michael W. Roe1,*
1Department of Medicine, University of Chicago, Chicago, IL 60637, USA
*Correspondence: l-philipson@uchicago.edu (L.H.P.), mroe@medicine.bsd.uchicago.edu (M.W.R.)
DOI 10.1016/j.cmet.2008.03.009
BAD, a proapoptotic member of the Bcl-2 family of proteins, is regulated by phosphorylation. A recent study
(Danial et al., 2008) suggests a phosphorylation-state-dependent bifunctional role of BAD in the regulation of
glucose-stimulated insulin secretion and b cell mass.Interplay between pro- and antiapoptotic
members of the Bcl-2 family of proteins
regulates apoptosis by controlling mito-
chondrial cell death signaling and cas-
pase activation. BAD (Bcl-xL/Bcl-2-asso-
ciated death promoter homolog, or Bcl
antagonist of cell death) was the first
proapoptotic member of the Bcl family
to be described. BAD alone is a relatively
weak inducer of apoptosis requiring bind-
ing with other Bcl proteins for full activity.
BAD interaction with a multiprotein com-
plex consisting of Bcl-xL/Bcl-2 and BAK/
BAX triggers apoptosis and is determined
by the phosphorylation state of BAD.
Although the precise mechanisms are
not completely understood, the dephos-
phorylated BAD BH3 domain binds and
inhibits antiapoptotic Bcl-xL and dere-
presses proapoptotic BAK/BAX. BAK
and BAX aggregate in and permeabilize
the mitochondrial outer membrane, facili-
tating release of proapoptotic mitochon-
drial proteins into the cytoplasm, apopto-
some assembly, and activation of cellular
executing caspases.
BAD appears to be a multifunctional
protein capable of participating in both
cellular survival and death pathways.
BAD is a substrate for several antiapo-
ptotic kinases, including protein kinase A
(PKA) and protein kinase B (PKB or Akt).
Serine phosphorylation of BAD and for-
mation of an inactive complex between
phospho-BAD and 14-3-3 proteins may
be important cellular survival signals. In
mouse hepatocytes, phosphorylated
BAD regulates glucose metabolism and
mitochondrial bioenergetics. Bad knock-
out mice and expression of an unphos-
phorylated form of BAD have confirmed
an unexpected role of phosphorylated
BAD inmitochondrial function, specifically
regulating glucokinase (GK; hexokinase
IV) in hepatocytes (Danial et al., 2003).
Phospho-BAD is necessary for the forma-280 Cell Metabolism 7, April 2008 ª2008 Elstion of a functional holoenzyme complex
with GK, PKA, protein phosphatase 1
(PP1), andWiskott-Aldrich syndrome pro-
tein (WASP)-family verprolin-homologous
protein 1 (WAVE1) (Danial et al., 2003).
A recent study (Danial et al., 2008) dem-
onstrated a central role of BAD in the
physiological regulation of insulin secre-
tion and b cell mass. In transgenic Bad/
mice, b cell function and GK activity were
impaired. The first phase of glucose-
stimulated insulin secretion (GSIS) was
inhibited, and responses to other secreta-
gogues were unaffected. Complementary
genetic and biochemical strategies were
used to inhibit and rescue phospho-BAD
function and establish that phosphoryla-
tion of the BAD BH3 domain at Ser155 is
required for GSIS and binding to GK. In
addition to regulating metabolism, BAD
phosphorylationmay also be an important
survival signal in b cells. Phosphorylated
BAD levels are elevated in islets from
Zucker diabetic fatty rats prior to the on-
set of diabetes (Jetton et al., 2005), and
high-fat feeding increases Bad mRNA
expression in mouse islets (Danial et al.,
2008). The increased b cell proliferation
seen in chronic mild hyperglycemia in
a ratmodelwasdue to both increased sur-
vival and neogenesis of b cells rather than
proliferation (Jetton et al., 2008), although
in a similar glucose-infusedmousemodel,
replication was enhanced but death rates
were unchanged (Alonso et al., 2007). In-
terestingly, a transgenic mouse model for
overexpression of Bcl-xL,a possible com-
petitor of glucokinase for BAD binding,
inhibited b cell death but impaired mito-
chondrial function, resulting in decreased
insulin secretion (Zhou et al., 2000). Future
studies may be directed at determining
whether there is in fact decreased apopto-
sis in high-fat-fed Bad/ mouse islets.
Their b cells do seem to have a survival ad-
vantage despite decreased insulin secre-evier Inc.tion, reminiscent of Bcl-xL-overexpressing
mice (Zhou et al., 2000). Despite the de-
creased insulin secretory capacity, the
increase in islet number in response to
high-fat feeding in Bad/ mice compen-
sates for the defect. Isletmass compensa-
tion was not seen in a transgenic knockin
mouse expressing a mutant of BAD
(Bad3SA) with enhanced proapoptotic ac-
tivity, suggesting that the two functions of
BAD are separable (Danial et al., 2008).
The direct interaction between BAD
and GK may provide additional insights
into the pathogenesis of diabetes. In the
human form of monogenic diabetes
caused by GK mutations, mature onset
diabetes of the young, type 2 (MODY2),
some of theGKmutations are functionally
intact but still causemild diabetes. For ex-
ample, three GK mutants, R36W, A53S,
and V367M, have kinetic and thermal sta-
bility properties similar to those of wild-
type GK (Miller et al., 1999). These have
been thought to causeMODY2by adefect
in protein-protein interactions. The muta-
tions are all on the external surface of
GK, based on computer modeling, and
far from the active site: do they lack
a BAD BH3 binding site? These residues
(especially R36 and A53 in the amino ter-
minus of GK) could form a potential inter-
action domain with BAD BH3.
Since apoptosis and cellular metabo-
lism converge at the mitochondrion, this
suggests a unifying hypothesis tying to-
gether etiologies of insulin resistance
and b cell dysfunction leading to type 2 di-
abetes mellitus (T2DM) (Muoio and New-
gard, 2008). A growing list of b cell defects
in type 2 diabetes includes altered mito-
chondrial calcium and morphology, im-
paired glucose oxidation, and reduced
ATP generation along with a relative
decrease in functional b cell mass (Wie-
derkehr and Wollheim, 2008). Muscle
cells from obese fa/fa rats have reduced
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chondrial fragmentation, andmultiple bio-
energetic defects that likely decrease
insulin effectiveness (Bach et al., 2003).
Proapoptotic BAX binds to mitochondrial
fission sites, interacts there with mito-
chondrial fission proteins, and may play
a role in apoptotic mitochondrial fragmen-
tation. BAX or BAK is required for mito-
chondrial fusion in normal fibroblasts and
kidney cell lines (Karbowski et al., 2006).
Early dysregulation of the BAD-GK com-
plex due to phosphorylation or decreased
mitochondrial binding could cause de-
creased insulin secretion, perhaps in
part mediated by reactive oxygen species
(ROS) production in the mitochondria
leading to further BAX release, stimulating
mitochondrial fission in diabetic islets.
T2DM is thought to arise from a lack of
functional b cell mass in the face of insulin
resistance. Overwork of b cells in a failed
attempt to compensate for increased in-
sulin demand could contribute to a defect
in the BAD-GK-mitochondrion interac-
tion, setting off a cascade of events lead-
ing to further insulin resistance and hyper-
glycemia (Fridlyand and Philipson, 2004;
Muoio and Newgard, 2008). Although in-
creased GSIS might temporarily improve
the diabetic state, oxidative stress conse-
quent to overproduction of ROS by both
oxidative phosphorylation in mitochon-Fly-let Biology and
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In Drosophila, a simple network of n
b cells, regulates carbohydrate me
2008) shows that signals from these
to dietary protein and carbohydrate
The modern, postgenome era is seeing
a resurgence of insect physiology, focus-
ing on Drosophila as a model system. A
key question to address is, how do nutri-
tion and endocrine circuits affect gene
expression? This question is of particulardria and elevated proinsulin translation in
the endoplasmic reticulum may eventu-
ally lead to b cell failure (Fridlyand and
Philipson, 2004). Integrating causes of
both insulin resistance and b cell failure
due to metabolic stress factors would
lead to a unifying mechanistic hypothesis
for T2DM (Muoio and Newgard, 2008).
Treatment interventions targeting muscle
mitochondrial function or number could
improve insulin resistance pathways,
which would reduce the demand for insu-
lin. Simultaneously, functional inhibition of
b cells along with incretin agonist therapy
might allow recovery from metabolic
stress. Together, these approaches in ef-
fect could replicate the impressive results
in ameliorating or preventing T2DM
achieved by intensive exercise and signif-
icant weight loss. By establishing BAD
as an important metabolic and survival
sensor in b cells, Danial and colleagues
(2008) have provided exciting new infor-
mation necessary for improving our un-
derstanding of b cell biology and possible
mechanisms underlying the pathophysiol-
ogy of the growing epidemic of diabetes.
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